Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.

Share this video  

IMS 2023 | Session highlights: practical aspects of immunotherapy in multiple myeloma

Noopur Raje, MD, Massachusetts General Hospital, Boston, MA, gives an overview of a session held at this year’s meeting which focused on practical aspects of immunotherapy in multiple myeloma. Dr Raje highlights some of the topics that were addressed, including novel data on CAR-T therapy and bispecific antibodies, and further summarizes some of the presentations that took place during the session. This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.